Oral Cephalosporin Market
1 Study Coverage
1.1 Oral Cephalosporin Product Introduction
1.2 Global Oral Cephalosporin Outlook 2017 VS 2022 VS 2028
1.2.1 Global Oral Cephalosporin Sales in US$ Million for the Year 2017-2028
1.2.2 Global Oral Cephalosporin Sales in Volume for the Year 2017-2028
1.3 United States Oral Cephalosporin Outlook 2017 VS 2022 VS 2028
1.3.1 United States Oral Cephalosporin Sales in US$ Million for the Year 2017-2028
1.3.2 United States Oral Cephalosporin Sales in Volume for the Year 2017-2028
1.4 Oral Cephalosporin Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Oral Cephalosporin in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Oral Cephalosporin Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Oral Cephalosporin Market Dynamics
1.5.1 Oral Cephalosporin Industry Trends
1.5.2 Oral Cephalosporin Market Drivers
1.5.3 Oral Cephalosporin Market Challenges
1.5.4 Oral Cephalosporin Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Oral Cephalosporin Market Segment by Type
2.1.1 Cefotaxime Acid
2.1.2 Cephalexin
2.1.3 Amoxicillin
2.1.4 Others
2.2 Global Oral Cephalosporin Market Size by Type
2.2.1 Global Oral Cephalosporin Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Oral Cephalosporin Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Oral Cephalosporin Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Oral Cephalosporin Market Size by Type
2.3.1 United States Oral Cephalosporin Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Oral Cephalosporin Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Oral Cephalosporin Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Oral Cephalosporin Market Segment by Application
3.1.1 Hospital
3.1.2 Clinic
3.1.3 Medical Center
3.2 Global Oral Cephalosporin Market Size by Application
3.2.1 Global Oral Cephalosporin Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Oral Cephalosporin Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Oral Cephalosporin Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Oral Cephalosporin Market Size by Application
3.3.1 United States Oral Cephalosporin Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Oral Cephalosporin Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Oral Cephalosporin Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Oral Cephalosporin Competitor Landscape by Company
4.1 Global Oral Cephalosporin Market Size by Company
4.1.1 Top Global Oral Cephalosporin Manufacturers Ranked by Revenue (2021)
4.1.2 Global Oral Cephalosporin Revenue by Manufacturer (2017-2022)
4.1.3 Global Oral Cephalosporin Sales by Manufacturer (2017-2022)
4.1.4 Global Oral Cephalosporin Price by Manufacturer (2017-2022)
4.2 Global Oral Cephalosporin Concentration Ratio (CR)
4.2.1 Oral Cephalosporin Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Oral Cephalosporin in 2021
4.2.3 Global Oral Cephalosporin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Oral Cephalosporin Manufacturing Base Distribution, Product Type
4.3.1 Global Oral Cephalosporin Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Oral Cephalosporin Product Type
4.3.3 Date of International Manufacturers Enter into Oral Cephalosporin Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Oral Cephalosporin Market Size by Company
4.5.1 Top Oral Cephalosporin Players in United States, Ranked by Revenue (2021)
4.5.2 United States Oral Cephalosporin Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Oral Cephalosporin Sales by Players (2020, 2021 & 2022)
5 Global Oral Cephalosporin Market Size by Region
5.1 Global Oral Cephalosporin Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Oral Cephalosporin Market Size in Volume by Region (2017-2028)
5.2.1 Global Oral Cephalosporin Sales in Volume by Region: 2017-2022
5.2.2 Global Oral Cephalosporin Sales in Volume Forecast by Region (2023-2028)
5.3 Global Oral Cephalosporin Market Size in Value by Region (2017-2028)
5.3.1 Global Oral Cephalosporin Sales in Value by Region: 2017-2022
5.3.2 Global Oral Cephalosporin Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Oral Cephalosporin Market Size YoY Growth 2017-2028
6.1.2 North America Oral Cephalosporin Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Oral Cephalosporin Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Oral Cephalosporin Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Oral Cephalosporin Market Size YoY Growth 2017-2028
6.3.2 Europe Oral Cephalosporin Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Oral Cephalosporin Market Size YoY Growth 2017-2028
6.4.2 Latin America Oral Cephalosporin Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Oral Cephalosporin Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Oral Cephalosporin Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 GSK
7.1.1 GSK Corporation Information
7.1.2 GSK Description and Business Overview
7.1.3 GSK Oral Cephalosporin Sales, Revenue and Gross Margin (2017-2022)
7.1.4 GSK Oral Cephalosporin Products Offered
7.1.5 GSK Recent Development
7.2 Lupin Pharmaceuticals
7.2.1 Lupin Pharmaceuticals Corporation Information
7.2.2 Lupin Pharmaceuticals Description and Business Overview
7.2.3 Lupin Pharmaceuticals Oral Cephalosporin Sales, Revenue and Gross Margin (2017-2022)
7.2.4 Lupin Pharmaceuticals Oral Cephalosporin Products Offered
7.2.5 Lupin Pharmaceuticals Recent Development
7.3 Sanofi
7.3.1 Sanofi Corporation Information
7.3.2 Sanofi Description and Business Overview
7.3.3 Sanofi Oral Cephalosporin Sales, Revenue and Gross Margin (2017-2022)
7.3.4 Sanofi Oral Cephalosporin Products Offered
7.3.5 Sanofi Recent Development
7.4 Ankur Drugs and Pharma Ltd
7.4.1 Ankur Drugs and Pharma Ltd Corporation Information
7.4.2 Ankur Drugs and Pharma Ltd Description and Business Overview
7.4.3 Ankur Drugs and Pharma Ltd Oral Cephalosporin Sales, Revenue and Gross Margin (2017-2022)
7.4.4 Ankur Drugs and Pharma Ltd Oral Cephalosporin Products Offered
7.4.5 Ankur Drugs and Pharma Ltd Recent Development
7.5 SAKAR
7.5.1 SAKAR Corporation Information
7.5.2 SAKAR Description and Business Overview
7.5.3 SAKAR Oral Cephalosporin Sales, Revenue and Gross Margin (2017-2022)
7.5.4 SAKAR Oral Cephalosporin Products Offered
7.5.5 SAKAR Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Oral Cephalosporin Industry Chain Analysis
8.2 Oral Cephalosporin Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Oral Cephalosporin Distributors
8.3 Oral Cephalosporin Production Mode & Process
8.4 Oral Cephalosporin Sales and Marketing
8.4.1 Oral Cephalosporin Sales Channels
8.4.2 Oral Cephalosporin Distributors
8.5 Oral Cephalosporin Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Oral Cephalosporin CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
Table 2. Oral Cephalosporin Market Trends
Table 3. Oral Cephalosporin Market Drivers
Table 4. Oral Cephalosporin Market Challenges
Table 5. Oral Cephalosporin Market Restraints
Table 6. Global Oral Cephalosporin Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Oral Cephalosporin Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Oral Cephalosporin Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Oral Cephalosporin Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Oral Cephalosporin Manufacturers in Global Market, Ranking by Revenue (2021)
Table 11. Global Oral Cephalosporin Revenue by Manufacturer, (US$ Million), 2017-2022
Table 12. Global Oral Cephalosporin Revenue Share by Manufacturer, 2017-2022
Table 13. Global Oral Cephalosporin Sales by Manufacturer, (K MT), 2017-2022
Table 14. Global Oral Cephalosporin Sales Share by Manufacturer, 2017-2022
Table 15. Global Oral Cephalosporin Price by Manufacturer (2017-2022) & (USD/MT)
Table 16. Global Oral Cephalosporin Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Oral Cephalosporin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Cephalosporin as of 2021)
Table 18. Top Players of Oral Cephalosporin in Global Market, Headquarters and Distribution of Producing Region
Table 19. Manufacturers Oral Cephalosporin Product Type
Table 20. Date of International Manufacturers Enter into Oral Cephalosporin Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Top Oral Cephalosporin Players in United States Market, Ranking by Revenue (2021)
Table 23. United States Oral Cephalosporin Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 24. United States Oral Cephalosporin Revenue Share by Players, 2020, 2021 & 2022
Table 25. United States Oral Cephalosporin Sales by Players, (K MT), 2020, 2021 & 2022
Table 26. United States Oral Cephalosporin Sales Share by Players, 2020, 2021 & 2022
Table 27. Global Oral Cephalosporin Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 28. Global Oral Cephalosporin Sales in Volume by Region (2017-2022) & (K MT)
Table 29. Global Oral Cephalosporin Sales in Volume Forecast by Region (2023-2028) & (K MT)
Table 30. Global Oral Cephalosporin Sales in Value by Region (2017-2022) & (US$ Million)
Table 31. Global Oral Cephalosporin Sales in Value Forecast by Region (2023-2028) & (US$ Million)
Table 32. North America Oral Cephalosporin Sales in Volume by Country (2017-2028) & (K MT)
Table 33. North America Oral Cephalosporin Sales in Value by Country (2017-2028) & (US$ Million)
Table 34. Asia Pacific Oral Cephalosporin Sales in Volume by Region (2017-2028) & (K MT)
Table 35. Asia Pacific Oral Cephalosporin Sales in Value by Region (2017-2028) & (US$ Million)
Table 36. Europe Oral Cephalosporin Sales in Volume by Country (2017-2028) & (K MT)
Table 37. Europe Oral Cephalosporin Sales in Value by Country (2017-2028) & (US$ Million)
Table 38. Latin America Oral Cephalosporin Sales in Volume by Country (2017-2028) & (K MT)
Table 39. Latin Americaa Oral Cephalosporin Sales in Value by Country (2017-2028) & (US$ Million)
Table 40. Middle East and Africa Oral Cephalosporin Sales in Volume by Country (2017-2028) & (K MT)
Table 41. Middle East and Africa Oral Cephalosporin Sales in Value by Country (2017-2028) & (US$ Million)
Table 42. GSK Corporation Information
Table 43. GSK Description and Business Overview
Table 44. GSK Oral Cephalosporin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 45. GSK Oral Cephalosporin Product
Table 46. GSK Recent Development
Table 47. Lupin Pharmaceuticals Corporation Information
Table 48. Lupin Pharmaceuticals Description and Business Overview
Table 49. Lupin Pharmaceuticals Oral Cephalosporin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 50. Lupin Pharmaceuticals Product
Table 51. Lupin Pharmaceuticals Recent Development
Table 52. Sanofi Corporation Information
Table 53. Sanofi Description and Business Overview
Table 54. Sanofi Oral Cephalosporin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 55. Sanofi Product
Table 56. Sanofi Recent Development
Table 57. Ankur Drugs and Pharma Ltd Corporation Information
Table 58. Ankur Drugs and Pharma Ltd Description and Business Overview
Table 59. Ankur Drugs and Pharma Ltd Oral Cephalosporin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 60. Ankur Drugs and Pharma Ltd Product
Table 61. Ankur Drugs and Pharma Ltd Recent Development
Table 62. SAKAR Corporation Information
Table 63. SAKAR Description and Business Overview
Table 64. SAKAR Oral Cephalosporin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 65. SAKAR Product
Table 66. SAKAR Recent Development
Table 67. Key Raw Materials Lists
Table 68. Raw Materials Key Suppliers Lists
Table 69. Oral Cephalosporin Customers List
Table 70. Oral Cephalosporin Distributors List
Table 71. Research Programs/Design for This Report
Table 72. Key Data Information from Secondary Sources
Table 73. Key Data Information from Primary Sources
List of Figures
Figure 1. Oral Cephalosporin Product Picture
Figure 2. Global Oral Cephalosporin Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Oral Cephalosporin Market Size 2017-2028 (US$ Million)
Figure 4. Global Oral Cephalosporin Sales 2017-2028 (K MT)
Figure 5. United States Oral Cephalosporin Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 6. United States Oral Cephalosporin Market Size 2017-2028 (US$ Million)
Figure 7. United States Oral Cephalosporin Sales 2017-2028 (K MT)
Figure 8. United States Oral Cephalosporin Market Share in Global, in Value (US$ Million) 2017-2028
Figure 9. United States Oral Cephalosporin Market Share in Global, in Volume (K MT) 2017-2028
Figure 10. Oral Cephalosporin Report Years Considered
Figure 11. Product Picture of Cefotaxime Acid
Figure 12. Product Picture of Cephalexin
Figure 13. Product Picture of Amoxicillin
Figure 14. Product Picture of Others
Figure 15. Global Oral Cephalosporin Market Share by Type in 2022 & 2028
Figure 16. Global Oral Cephalosporin Sales in Value by Type (2017-2028) & (US$ Million)
Figure 17. Global Oral Cephalosporin Sales Market Share in Value by Type (2017-2028)
Figure 18. Global Oral Cephalosporin Sales by Type (2017-2028) & (K MT)
Figure 19. Global Oral Cephalosporin Sales Market Share in Volume by Type (2017-2028)
Figure 20. Global Oral Cephalosporin Price by Type (2017-2028) & (USD/MT)
Figure 21. United States Oral Cephalosporin Market Share by Type in 2022 & 2028
Figure 22. United States Oral Cephalosporin Sales in Value by Type (2017-2028) & (US$ Million)
Figure 23. United States Oral Cephalosporin Sales Market Share in Value by Type (2017-2028)
Figure 24. United States Oral Cephalosporin Sales by Type (2017-2028) & (K MT)
Figure 25. United States Oral Cephalosporin Sales Market Share in Volume by Type (2017-2028)
Figure 26. United States Oral Cephalosporin Price by Type (2017-2028) & (USD/MT)
Figure 27. Product Picture of Hospital
Figure 28. Product Picture of Clinic
Figure 29. Product Picture of Medical Center
Figure 30. Global Oral Cephalosporin Market Share by Application in 2022 & 2028
Figure 31. Global Oral Cephalosporin Sales in Value by Application (2017-2028) & (US$ Million)
Figure 32. Global Oral Cephalosporin Sales Market Share in Value by Application (2017-2028)
Figure 33. Global Oral Cephalosporin Sales by Application (2017-2028) & (K MT)
Figure 34. Global Oral Cephalosporin Sales Market Share in Volume by Application (2017-2028)
Figure 35. Global Oral Cephalosporin Price by Application (2017-2028) & (USD/MT)
Figure 36. United States Oral Cephalosporin Market Share by Application in 2022 & 2028
Figure 37. United States Oral Cephalosporin Sales in Value by Application (2017-2028) & (US$ Million)
Figure 38. United States Oral Cephalosporin Sales Market Share in Value by Application (2017-2028)
Figure 39. United States Oral Cephalosporin Sales by Application (2017-2028) & (K MT)
Figure 40. United States Oral Cephalosporin Sales Market Share in Volume by Application (2017-2028)
Figure 41. United States Oral Cephalosporin Price by Application (2017-2028) & (USD/MT)
Figure 42. North America Oral Cephalosporin Sales in Volume Growth Rate 2017-2028 (K MT)
Figure 43. North America Oral Cephalosporin Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 44. U.S. Oral Cephalosporin Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 45. Canada Oral Cephalosporin Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 46. Europe Oral Cephalosporin Sales in Volume Growth Rate 2017-2028 (K MT)
Figure 47. Europe Oral Cephalosporin Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 48. Germany Oral Cephalosporin Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 49. France Oral Cephalosporin Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 50. U.K. Oral Cephalosporin Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 51. Italy Oral Cephalosporin Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 52. Russia Oral Cephalosporin Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 53. Asia-Pacific Oral Cephalosporin Sales in Volume Growth Rate 2017-2028 (K MT)
Figure 54. Asia-Pacific Oral Cephalosporin Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 55. China Oral Cephalosporin Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 56. Japan Oral Cephalosporin Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 57. South Korea Oral Cephalosporin Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 58. India Oral Cephalosporin Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 59. Australia Oral Cephalosporin Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 60. Taiwan Oral Cephalosporin Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 61. Indonesia Oral Cephalosporin Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 62. Thailand Oral Cephalosporin Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 63. Malaysia Oral Cephalosporin Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 64. Philippines Oral Cephalosporin Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 65. Latin America Oral Cephalosporin Sales in Volume Growth Rate 2017-2028 (K MT)
Figure 66. Latin America Oral Cephalosporin Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 67. Mexico Oral Cephalosporin Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 68. Brazil Oral Cephalosporin Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 69. Argentina Oral Cephalosporin Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 70. Middle East & Africa Oral Cephalosporin Sales in Volume Growth Rate 2017-2028 (K MT)
Figure 71. Middle East & Africa Oral Cephalosporin Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 72. Turkey Oral Cephalosporin Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 73. Saudi Arabia Oral Cephalosporin Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 74. U.A.E Oral Cephalosporin Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 75. Oral Cephalosporin Value Chain
Figure 76. Oral Cephalosporin Production Process
Figure 77. Channels of Distribution
Figure 78. Distributors Profiles
Figure 79. Bottom-up and Top-down Approaches for This Report
Figure 80. Data Triangulation
Figure 81. Key Executives Interviewed
Industry Market Size
